2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012
06/07/17
Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook
06/05/17
Organovo to Present at Jefferies Healthcare Conference
05/18/17
Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues at World Advanced Therapies and Regenerative Medicine Congress
05/17/17
Organovo Announces Release Date for Fiscal Fourth-Quarter 2017 Financial Results
05/01/17
Organovo Collaborates With University of Virginia to Develop Bioprinted Tissues for Volumetric Muscle Loss Injury
04/24/17
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/11/17
Organovo Announces CEO Transition
03/13/17
Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver and Kidney Tissues for Drug Toxicity Testing
03/09/17
Organovo to Present at 29th Annual Roth Conference
02/21/17
Organovo Publishes Data Describing Physiology of 3D Bioprinted Human Kidney Tissues for Drug Toxicity Testing
02/09/17
Organovo Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook
01/24/17
Organovo Collaborates With Professor Melissa Little for Kidney Tissue Research
01/19/17
Organovo Announces Release Date for Fiscal Third-Quarter 2017 Financial Results
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet
MENU